FI860296A0 - Nya tieno-triazolo-1,4 -diazepino-2-kolsyraamider, foerfarande foer deras framstaellning och farmaceutiska sammansaettningar. - Google Patents

Nya tieno-triazolo-1,4 -diazepino-2-kolsyraamider, foerfarande foer deras framstaellning och farmaceutiska sammansaettningar.

Info

Publication number
FI860296A0
FI860296A0 FI860296A FI860296A FI860296A0 FI 860296 A0 FI860296 A0 FI 860296A0 FI 860296 A FI860296 A FI 860296A FI 860296 A FI860296 A FI 860296A FI 860296 A0 FI860296 A0 FI 860296A0
Authority
FI
Finland
Prior art keywords
carbon atoms
halogen
diazepino
triazolo
chained
Prior art date
Application number
FI860296A
Other languages
English (en)
Other versions
FI86851B (fi
FI86851C (fi
FI860296A (fi
Inventor
Karl-Heinz Weber
Gerhard Walther
Albrecht Harreus
Jorge Casals-Stenzel
Gojki Muacevic
Wolfgang Troeger
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of FI860296A0 publication Critical patent/FI860296A0/fi
Publication of FI860296A publication Critical patent/FI860296A/fi
Publication of FI86851B publication Critical patent/FI86851B/fi
Application granted granted Critical
Publication of FI86851C publication Critical patent/FI86851C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI860296A 1985-01-25 1986-01-22 Foerfarande foer framstaellning av farmaceutiskt verksamma tieno-triatzolo-1,4-diazepino-2-karboxylsyraamider FI86851C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3502392 1985-01-25
DE19853502392 DE3502392A1 (de) 1985-01-25 1985-01-25 Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen

Publications (4)

Publication Number Publication Date
FI860296A0 true FI860296A0 (fi) 1986-01-22
FI860296A FI860296A (fi) 1986-07-26
FI86851B FI86851B (fi) 1992-07-15
FI86851C FI86851C (fi) 1992-10-26

Family

ID=6260695

Family Applications (1)

Application Number Title Priority Date Filing Date
FI860296A FI86851C (fi) 1985-01-25 1986-01-22 Foerfarande foer framstaellning av farmaceutiskt verksamma tieno-triatzolo-1,4-diazepino-2-karboxylsyraamider

Country Status (28)

Country Link
US (3) US4968794A (fi)
EP (1) EP0194416B1 (fi)
JP (2) JPH0633278B2 (fi)
KR (1) KR920010711B1 (fi)
AT (1) ATE42556T1 (fi)
AU (1) AU584663B2 (fi)
CA (1) CA1269373A (fi)
CS (1) CS254992B2 (fi)
CZ (1) CZ410791A3 (fi)
DD (3) DD263063A5 (fi)
DE (2) DE3502392A1 (fi)
DK (2) DK165323C (fi)
ES (3) ES8704949A1 (fi)
FI (1) FI86851C (fi)
GR (1) GR860189B (fi)
HK (1) HK75792A (fi)
HU (2) HU195821B (fi)
IE (1) IE58728B1 (fi)
IL (1) IL77702A (fi)
MX (1) MX9203258A (fi)
NO (2) NO164029C (fi)
NZ (1) NZ214926A (fi)
PL (1) PL144948B1 (fi)
PT (1) PT81898B (fi)
SG (1) SG44292G (fi)
SU (1) SU1402265A3 (fi)
YU (2) YU44280B (fi)
ZA (1) ZA86542B (fi)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
DE3778559D1 (de) * 1986-01-21 1992-06-04 Boehringer Ingelheim Kg Thieno-1,4-diazepine.
DE3610848A1 (de) * 1986-04-01 1987-10-15 Boehringer Ingelheim Kg Neue 1,4-diazepine
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
DE3745135C2 (de) * 1986-10-21 1999-05-12 Korth Ruth Verwendung von hydrophilen Triazolothieno-diazepinen zur Behandlung von Arteriosklerose
EP0268242B1 (en) * 1986-11-17 1992-03-18 Yoshitomi Pharmaceutical Industries, Ltd. Paf-antagonistic thienotriazolodiazepine compounds and pharmaceutical uses thereof
DE3725130C2 (de) * 1987-07-29 1996-12-12 Boehringer Ingelheim Kg Tritium-oder ·1··4·C-markiertes 4-(2-Chlorphenyl)-9-methyl-2-[3-(4-morpholinyl)-3-propanon-1-yl]-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin, Verfahren zu deren Herstellung und deren Verwendung als Radiorezeptorassay sowie zu diagnostischen Zwecken
US5895785A (en) * 1987-10-20 1999-04-20 Ruth Korth Treatment and prevention of disorders mediated by LA-paf or endothelial cells
US4959361A (en) * 1987-12-18 1990-09-25 Hoffmann-La Roche Inc. Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists
CA1324863C (en) * 1988-01-30 1993-11-30 Minoru Moriwaki Thienotriazolodiazepine compounds and pharmaceutical uses thereof
EP0338993A1 (en) * 1988-04-21 1989-10-25 Sandoz Ag 6-Aryl-substituted-4h-thieno[2,3-e][1,2,4]triazolo [3,4-c][1,4]diazepines
US5334592A (en) * 1988-04-27 1994-08-02 Schering Corporation Certain PAF antagonist antihistamine combinations and methods
DE68904475T2 (de) * 1988-04-27 1993-05-13 Schering Corp Gewisse paf-antagonist/antihistamin-mischungen und verfahren.
CA1322367C (en) * 1988-05-17 1993-09-21 Yoshitomi Pharmaceutical Industries Ltd. Thienotriazolodiazepine compounds and pharmaceutical uses thereof
US5382579A (en) * 1988-10-31 1995-01-17 Eisai Co., Ltd. Triazolo-1,4-diazepine derivatives and their use in pharmaceuticals
US5304553A (en) * 1988-10-31 1994-04-19 Eisai Co., Ltd. 1,4-diazepine derivative and its pharmaceutical use
US5468740A (en) * 1988-10-31 1995-11-21 Eisai Co., Ltd. 1,4-diazepine derivative and its pharmaceutical use
US5221671A (en) * 1988-10-31 1993-06-22 Eisai Co., Ltd. Triazolo-1,4-diazepine derivatives and their use in pharmaceuticals
RU2117670C1 (ru) * 1988-10-31 1998-08-20 Эйсай Ко., Лтд. Производные триазоло[1,4]диазепина и способы их получения
FI95708C (fi) 1988-10-31 1996-03-11 Eisai Co Ltd Analogiamenetelmä 1,4-diatsepiinijohdannaisen ja sen farmaseuttisesti sopivan suolan valmistamiseksi
EP0387613A1 (de) * 1989-03-03 1990-09-19 Boehringer Ingelheim Kg Neue Thienodiazepine
DE4010528A1 (de) * 1990-04-02 1991-10-17 Boehringer Ingelheim Kg Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
EP0532512B1 (en) * 1990-05-31 1996-12-11 Allergan, Inc. Use of platelet activating factor antagonists as anti-pruritic agents
DE4027470A1 (de) * 1990-08-30 1992-03-05 Boehringer Ingelheim Kg Neue hetrazepinoide amide
DE4128579A1 (de) * 1991-08-28 1993-03-04 Boehringer Ingelheim Kg Verwendung von 4-(2-chlorphenyl)-9-methyl-2-(3(4-morpholinyl)-3-propanon-1-y1)-6h-thieno-(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin zur behandlung der allergischen rhinitis
DE540767T1 (de) * 1991-11-04 2001-10-25 Ruth-Maria Korth Behandlung und Vorbeugung von von erhöhten Lyso-PAF-Spiegel mediierten mentalen Erkrankungen mit PAF-Antagonisten
TW219935B (fi) * 1991-12-25 1994-02-01 Mitsubishi Chemicals Co Ltd
DE4200619A1 (de) * 1992-01-13 1993-07-15 Boehringer Ingelheim Kg Verwendung von 4-(2-chlorphenyl)-9-methyl-2-/3(4-morpholinyl)-3-propanon-1-yl/-6h-thieno-/3,2-f//1,2,4/ triazolo/4,3-a//1,4/diazepin zur behandlung der dysmenorrhes
GB9207645D0 (en) * 1992-04-08 1992-05-27 Smithkline Beecham Corp Methods
WO1994004537A2 (en) * 1992-08-20 1994-03-03 Cytomed, Inc. Dual functional anti-inflammatory and immunosuppressive agents
US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5302590A (en) * 1992-12-18 1994-04-12 Hoffmann-La Roche Inc. Compounds useful as dual antagonists of platelet activating factor and leukotriene D4
KR970707131A (ko) * 1994-11-08 1997-12-01 다께다 구니오 티에노피리딘 또는 티에노피리미딘 유도체 및 그의 용도(thienopyridine or thienopyrimidine derivatives and their use)
US6433167B1 (en) 1997-06-25 2002-08-13 Nikken Chemicals Co., Ltd. Triazolo-1,4-diazepine compounds and medicinal composition containing the same
NZ543741A (en) 2003-05-30 2009-10-30 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as HMG-Co inhibitors
US7223167B2 (en) * 2005-04-01 2007-05-29 Cnh America Llc Anti-wind wiper with adjustable extension
JP2009514851A (ja) 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド (3r,5r)−7−[2−(4−フルオロフェニル)−5−イソプロピル−3−フェニル−4−[(4−ヒドロキシメチルフェニルアミノ)カルボニル]−ピロール−1−イル]−3,5−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
US9638493B2 (en) 2011-11-26 2017-05-02 Orval E. Bowman Pointing devices, apparatus, systems and methods for high shock environments
CR20230211A (es) 2020-11-16 2023-07-13 Boehringer Ingelheim Int Derivados de ciclopentatiofen carboxamida como antagonistas del receptor del factor de activación de plaquetas
US11992494B2 (en) 2021-12-22 2024-05-28 Boehringer Ingelheim International Gmbh Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12303A (en) * 1973-02-08 1979-01-16 Hoffmann La Roche Thienotriazolodiazepine derivatives
DE2503235A1 (de) * 1975-01-27 1976-07-29 Boehringer Sohn Ingelheim Neues verfahren zur herstellung von 8-brom-thieno-triazolo-1,4-diazepinen
US4201712A (en) * 1975-07-16 1980-05-06 Boehringer Ingelheim Gmbh Process for preparation of 6-aryl-4H-s-triazolo-[3,4-c]-thieno-[2,3-e]-1,4-diazepines
AU518438B2 (en) * 1978-04-26 1981-10-01 Boehringer Ingelheim International Gmbh Substituted 6-aryl-4h-s-triazolo-3,4-c-thieno-2,3-e-1,4-diazepines
AU520063B2 (en) * 1978-07-13 1982-01-14 Boehringer Ingelheim International Gmbh Substituted 4h-s-triazolo(3,4-c)thieno(2,3-e)1,4-diazepines
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
DE3778559D1 (de) * 1986-01-21 1992-06-04 Boehringer Ingelheim Kg Thieno-1,4-diazepine.
US4960770A (en) * 1987-05-28 1990-10-02 Yoshitomi Pharmaceutical Industries, Ltd. 2-alkyl thieno(triazolo)diazepine compounds and pharmaceutical uses thereof
US4959361A (en) * 1987-12-18 1990-09-25 Hoffmann-La Roche Inc. Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists
US4914096A (en) * 1988-04-21 1990-04-03 Sandoz Pharmaceuticals Corp. 6-aryl-substituted-4H-thieno(2,3-e)(1,2,4)triazolo(3,4-c)(1,4)diazepines

Also Published As

Publication number Publication date
ES8802426A1 (es) 1988-06-01
AU584663B2 (en) 1989-06-01
JPH0651704B2 (ja) 1994-07-06
PL257602A1 (en) 1987-05-04
NO164029C (no) 1990-08-22
YU79987A (en) 1988-06-30
ES557344A0 (es) 1988-07-16
AU5272886A (en) 1986-07-31
NO894640D0 (no) 1989-11-22
US5155103A (en) 1992-10-13
DD265899A5 (de) 1989-03-15
ES8704949A1 (es) 1987-04-16
IL77702A (en) 1989-02-28
PT81898B (pt) 1988-05-27
NO894640L (no) 1986-07-28
NO855260L (no) 1986-07-28
YU46049B (sh) 1992-12-21
CZ410791A3 (en) 1993-04-14
NO166646C (no) 1991-08-21
YU44280B (en) 1990-04-30
EP0194416B1 (de) 1989-04-26
US5082839A (en) 1992-01-21
EP0194416A1 (de) 1986-09-17
NZ214926A (en) 1989-04-26
ES8802523A1 (es) 1988-07-16
DK36786D0 (da) 1986-01-24
HU195821B (en) 1988-07-28
YU7886A (en) 1987-10-31
CA1269373A (en) 1990-05-22
IE860209L (en) 1986-07-25
JPS61176591A (ja) 1986-08-08
CS254992B2 (en) 1988-02-15
KR860005822A (ko) 1986-08-13
SG44292G (en) 1992-09-04
DD263063A5 (de) 1988-12-21
DD265799A5 (de) 1989-03-15
FI86851B (fi) 1992-07-15
GR860189B (en) 1986-05-26
NO166646B (no) 1991-05-13
SU1402265A3 (ru) 1988-06-07
DK46292A (da) 1992-04-06
ZA86542B (en) 1987-09-30
DK36786A (da) 1986-07-26
DE3663028D1 (en) 1989-06-01
US4968794A (en) 1990-11-06
IE58728B1 (en) 1993-11-03
DE3502392A1 (de) 1986-07-31
PT81898A (de) 1986-02-01
PL144948B1 (en) 1988-07-30
MX9203258A (es) 1992-07-01
HK75792A (en) 1992-10-09
HU193624B (en) 1987-11-30
HUT40441A (en) 1986-12-28
JPH02191281A (ja) 1990-07-27
ATE42556T1 (de) 1989-05-15
DK165323C (da) 1993-03-29
FI86851C (fi) 1992-10-26
ES557343A0 (es) 1988-06-01
FI860296A (fi) 1986-07-26
NO164029B (no) 1990-05-14
ES551198A0 (es) 1987-04-16
KR920010711B1 (ko) 1992-12-14
DK46292D0 (da) 1992-04-06
DK165323B (da) 1992-11-09
JPH0633278B2 (ja) 1994-05-02

Similar Documents

Publication Publication Date Title
FI860296A (fi) Nya tieno-triazolo-1,4 -diazepino-2-kolsyraamider, foerfarande foer deras framstaellning och farmaceutiska sammansaettningar.
DE3060314D1 (en) Heterocyclic spiro-amidines, their stereoisomers and optical isomers, methods for their preparation and medicaments containing them
ES548497A0 (es) Procedimiento para preparar compuestos de 3-amino-2,3-dihi- dro-1-benzoxepina

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BOEHRINGER INGELHEIM KG